Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Dementia 2020

About Conference

Neuroscience is the logical investigation of the sensory system. It is a multidisciplinary part of science that joins physiology, life structures, atomic science, Dementia, formative science, cytology, numerical displaying and brain science to comprehend the central and eminent properties of neurons and neural circuits. Neurologic disorders involve the spinal column or nerves, brain. The most common neurological disorders are Alzheimer's and Dementia 

Euro Dementia 2020 is honored and delighted to welcome the Scientists, Neurologists, Neuro-physicians, Critical Care Specialists, Doctors and experts from all over the world to attend our European Meeting on Dementia, Alzheimer's and Neurological Disorders  during May 07-08, 2020 in the city of Zagreb, Croatia.The conference is based on the theme Exceeding a vision on Mental Illness and Dementia Care, which will provide a global networking platform for all the attendees.

The gathering of this event will aim to enlighten causes, prevention and complications of Alzheimer’s disease, which is commonly called Dementia. The conference committee has created a successful collaboration among the neurologists, neurosurgeons, neuro-physicians, critical care specialists and field related experts from all over the world. This opportunity will provide a global platform to them for enlightening the subject matter towards the world. Euro Dementia 2020 is a specially designed conference which consists of keynote presentations, Oral talks, Poster presentations, Workshops, Panel Discussions and Exhibitions, Young Researcher Forums (YRF) and Best Poster Award.


Track 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease, vascular dementia, which occurs after a stroke, is the second most common dementia type.

  • Dementia With Lewy Bodies
  • Mixed dementia
  • Creutzfeldt–Jakob Disease
  • Parkinson’s Disease
  • Mild cognitive impairment
  • Frontotemporal dementia
  • Normal pressure hydrocephalus
  • Signs and symptoms of dementia

Track 2: Alzheimer ’s Disease

Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is not a normal part of aging.

  • Risk Factors of Alzheimer’s
  • Diagnosis of Alzheimer’s
  • Treatments of Alzheimer’s
  • Clinical Studies of Alzheimer’s
  • Alzheimer’s disease Pathophysiology and Disease Mechanisms

Track 3: Dementia and Ageing

Ageing: Not being able to remember details of a conversation or event that took place a year ago, Not being able to remember the name of an acquaintance, Forgetting things and events occasionally, Occasionally have difficulty finding words, You are worried about your memory but your relatives are not.

Dementia: Not being able to recall details of recent events or conversations, not recognizing or knowing the names of family members, Forgetting things or events more frequently, Frequent pauses and substitutions when finding words, Your relatives are worried about your memory, but you are not aware of any problems  

  • Neuro-anatomical changes in Ageing
  • Risk factors of Cognitive decline
  • Granulovacuolar Degeneration
  • Changes in Cerebral Cortical microvasculature
  • Advances of research in Ageing and Dementia

Track 4: Vascular Dementia

Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

  • Vascular Dementia Prognosis
  • Young onset Dementia
  • Multi-infarct Dementia
  • Mixed Dementia
  • Parkinson Dementia
  • Advances in Vascular Dementia therapy

Track 5: Geriatrics Dementia and Cognitive Disorders

Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. There’s no set age at that patients are also underneath the care of a specialist or geriatric.

  • Delirium
  • Mild and Major Neurocognitive Disorder

Track 6: Animal Models in Dementia

The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

  • Neurobehavioral Toxicology Testing
  • Pre-clinical testing and Clinical translation
  • Protein-protein interactions
  • Genetics of translational models
  • Animal models of human cognitive aging

Track 7: Amyloid Protein in Alzheimer’s and Dementia

Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyper phosphorylated and cleaved forms of the microtubule-associated protein tau.

  • Amyloid Imaging
  • Amyloid Immunotherapy

Track 8: Dementia Care Management

The developing number of vascular dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.

  • Advances in Dementia Care Management
  • Dementia Care Management Program
  • Under nutrition and obesity in dementia
  • Advance care planning

Track 9: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities.

  • Dementia Nursing care plan
  • Music therapy in Dementia
  • Dementia Physiotherapy
  • Clinical features of dementia
  • Dementia Therapeutic intervention

Track 10: Recent Advancement in Treating Dementia

Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable. Ischemic changes in the cerebrum are irreversible; however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus.

  • Primary mental health care and nursing
  • Psychopharmacological treatment
  • Advanced drugs for dementia
  • Cognitive behavioral therapy
  • Family therapy in nursing

Market Report

Dementia is a form of disease that affects the functioning of the brain resulting in decline in memory or other thinking skills. Alzheimer’s disease is the most common and largest form of dementia (in over 60% cases), which is observed among people aged 65 years and above. Accumulation of a protein called beta amyloid, in the spaces between nerve cells due to genetic mutation is a major cause of dementia. Although dementia disease is not treatable, symptomatic treatment is followed in all cases. Research is being carried out to develop treatment centered on the role of beta-amyloid in dementia.

The global dementia drugs market estimated to be valued at US$ 13,900.0 million in 2017 and is expected to witness a CAGR of 8.4% over the forecast period (2018–2026).

Past Conference Report

The conference was focused on the theme, “Decoding Dementia & Alzheimer's  disease.” and facilitated by the ConferenceSeries LLC Ltd. Liberal reaction and cooperation was received from the Editorial Board Members of  Associated Journals, Vascular Dementia 2019 Organizing Committee Members and researchers, analysts and pioneers in Dementia, and Vascular Dementia.

The conference was started by the Keynote Forum and we are pleased to thank all our Keynote Speakers, Honorable Guests, Speakers and Conference Attendees for creating a successful meeting.

The conference has encrusted through the following sessions:

Vascular Dementia and Stroke

Causes and Prevention

Vascular Cognitive Impairment

Dementia: Risk Factors

Prevention of Dementia

Dementia Stages

Ageing and Dementia

Advances in Dementia Diagnosis

Dementia Care Management

Dementia Nursing


Novel Therapeutics

Treating Dementia

Neurodegenerative Disorders

We would like to specially mention our Keynote Speakers who participated very enthusiastically and actively:

Hans von Holst, Karolinska University Hospital, Sweden

Anne L. Foundas, Brain Institute of Louisiana, USA

Brian Norris, Founder, Executive Director Living Memories C.I.C.UK

Shu G. Chen, USA Case Western Reserve University School of Medicine, USA

Nancy D. Broz, Rowan University, USA

Kyaien O. Conner, University of South Florida, USA

Morejoy Saineti, Greenwich University London, UK

Amarnath Mallik, Consultant Psychiatrist, India

Taheri Saeid, Byrd Alzheimers Institute, USA

David Truswell, Dementia Alliance for Culture and Ethnicity, UK

Jacqueline A Hinds, Society of Emotional Intelligence UK


Olessia Gorkovenko,oulos, UNISA, South Africa

The speakers gave their productive commitment as exceptionally enlightening presentations and made the meeting an extraordinary achievement.

We thank all the members who supported the conference by encouraging the healthy discussions. Vascular Dementia 2019 expresses gratitude to the Organizing Committee Members for their generous response, support and help towards

After the immense idealistic reaction from logical crew, prestigious identities and the Editorial Board Members we are pleased to announce our forth coming conference European Meeting on Dementia, Alzheimer's and Neurological Disorders to be held in Zagreb | Croatia, during May 07-08, 2020.

Let us meet again @ Euro Dementia 2020

To Collaborate Scientific Professionals around the World

Conference Date May 7-8, 2020

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Brain Disorders & Therapy Journal of Neurological Disorders

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by